News

BioAge, in a recent press release, has announced the start of its phase 2a clinical trial in elderly patients with unexplained anemia. BioAge is a California-based company founded in 2015 with a very direct focus on aging. It utilizes a systems biology approach and AI-based drug discovery platform to target important pathways which are found...

This is part one of a two-part article where we take a look at NAD+ biology, its history, how it relates to the biology of aging, and the potential for therapeutic interventions via the so-called NAD+ precursors. What is NAD+? Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in all living cells. It is a...

This week on Lifespan News, Brent Nally discusses longevity pharmacology, atrophy of the circadian clock, SIRT3 and lung fibrosis, research that suggests that we should look beyond biology to slow aging, and our Science to Save the World episode on ancestral memories. Further Reading Longevity Pharmacology Comes of Age Atrophy of the Neuronal Circadian Clock...

Almost three years ago, Dr. Matt Kaeberlein, a Professor of Pathology and an Adjunct Professor of both Genome Sciences and Oral Health Sciences at the University of Washington in Seattle, outlined the nascent Dog Aging Project (DAP) for our readers in an extensive interview. Along with the intrinsic value of helping our beloved pets live...

In this episode of X10, we discuss three reasons why people don't care about curing aging. Getting people to care about elderly dying from a deadly disease is relatively easy, but getting them to care about the cause of their frailty and immune susceptibility, aging itself, is a bit different. Sources The elderly are...

As rejuvenation research continues to grow and develop, so do we here at Lifespan.io. This month's Roundup features quite a few interesting studies along with things that we're doing to make these studies more accessible to the public. LEAF News Take Our Audience Survey!: We'd like to know your opinions and perspective on us and...